Potrelease TR Tablet Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

KCl

Indications/Uses

Hypokalaemia w/ or w/o metabolic alkalosis in digitalis intoxication & in patients w/ hypokalaemia familial periodic paralysis. Prophylaxis in patients w/ inadequate K dietary intake & in patients w/ digitalis & diuretic treatment.

Click to view Potrelease TR Tablet detailed prescribing information

Dosage/Direction for Use

Adult 600-1,200 mg tds.

Click to view Potrelease TR Tablet detailed prescribing information

Overdosage

View Potrelease TR Tablet overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Take w/ or immediately after meals. Swallow whole w/ a full glass of water, do not chew/crush tab.

Contraindications

Untreated Addison's disease, adynamia episodica-hereditaria, acute dehydration, heat cramps, hyperkalaemia, GI obstruction, abnormal ulceration motility, metabolic acidosis. Severe renal impairment w/ oliguria or azotemia.

Click to view Potrelease TR Tablet detailed prescribing information

Special Precautions

Concomitant use w/ adrenocorticoids, glucocorticoids or corticotrophin (ACTH); antimuscarinics eg, atropine; K-sparing diuretics eg, amiloride, spironolactone, triamterene or low-salt milk or K-containing medication or salt substitute; Ca salts; captoptril; digitalis glycosides; Na cycle exchange resins eg, Na polystyrene sulfonate; glucose-insulin or Na bicarbonate infusion; chronic laxative use; quinidine; vit B₁₂. Blood from blood bank. Not recommended in digitalized patients w/ severe or complete heart block. Not recommended in paed.

Adverse Reactions

Diarrhoea, nausea, stomach pain, vomiting.

Click to view Potrelease TR Tablet detailed prescribing information

Drug Interactions

Decreased effect w/ adrenocorticoids, glucocorticoids or corticotrophin (ACTH). Increased severity of GI lesions w/ antimuscarinics eg, atropine. Promote serum K accumulation w/ K-sparing diuretics eg, amiloride, spironolactone or triamterene, low-salt milk or K-containing medication or salt substitute. Precipitated cardiac arrhythmias w/ Ca salts. Hyperkalaemia w/ captopril. Monitor serum K conc w/ digitalis glycosides. Reduced conc w/ Na cycle exchange resins eg, Na polystyrene sulfonate, glucose-insulin or Na bicarbonate infusion, chronic laxative use. Enhanced quinidine's antiarrhythmic effect. Reduced vit B₁₂ absorption.

Click to view Potrelease TR Tablet detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Potrelease TR Tablet detailed prescribing information

Storage

View Potrelease TR Tablet storage conditions for details to ensure optimal shelf-life.

Description

View Potrelease TR Tablet description for details of the chemical structure and excipients (inactive components).

Action

View Potrelease TR Tablet mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Electrolytes

ATC Classification

A12BA01 - potassium chloride ; Belongs to the class of potassium-containing preparations. Used as dietary supplements.

Regulatory Classification

Presentation/Packing

Form

Potrelease TR FC tab 600 mg

Packing/Price

100 × 10's

Potrelease TR Tablet

potassium chloride

Manufacturer:

SM Pharmaceuticals

Distributor:

SM Pharmaceuticals